Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (2): 157-162    DOI: 10.31083/j.ejgo.2020.02.5226
Review | Next articles
Should we search for high-risk HPV in vaginal vault Pap smear after hysterectomy due to CIN2+?
I. Ferreira1, *(), C. Estevinho2, A. Torgal2, C. Carrapatoso2, F. Costa2
1 Serviço de Ginecologia e Obstetrìcia do Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
2 Serviço de Ginecologia e Obstetrìcia do Centro Hospitalar Tâmega e Sousa, Penafiel, Portugal
Download:  PDF(344KB)  ( 354 ) Full text   ( 20 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Women with a history of hysterectomy due to malignant or premalignant cervical disease are currently submitted to tight surveillance, which consists of vaginal Pap tests for as long as 20 years in the late follow-up period. Nevertheless, published literature has concluded that vaginal Pap screening has a very low detection yield. Also, these recommendations are almost entirely from an era before high-risk HPV (hrHPV) DNA testing. The authors' aim is to review these women's current management and share the scarce recommendations available for the management of abnormal vaginal Pap and/or adjunctive hrHPV DNA tests in these patients.
Key words:  Vaginal Pap tests      hrHPV vaginal testing      Follow-up      Hysterectomy      CIN2+     
Published:  15 April 2020     
*Corresponding Author(s):  I.FERREIRA     E-mail:  iolandaferreira04@gmail.com

Cite this article: 

I. Ferreira, C. Estevinho, A. Torgal, C. Carrapatoso, F. Costa. Should we search for high-risk HPV in vaginal vault Pap smear after hysterectomy due to CIN2+?. European Journal of Gynaecological Oncology, 2020, 41(2): 157-162.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.02.5226     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I2/157

[1] Youngsun Kim, Sungkyoung Moon, Kiyong Na. Metastatic mesonephric adenocarcinoma of unknown origin after hysterectomy: A case report[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 828-832.
[2] John P. Micha, Howard D. Epstein, Michael C. Roossin, Randy Bohart, Mark A. Rettenmaier, Bram H. Goldstein. Neoadjuvant chemotherapy, radical hysterectomy and chemoradiation for stage iva cervical carcinoma[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 797-801.
[3] Sun Yi Choe, Jung-Woo Park. Prognostic significance of the number of metastatic lymph nodes in early cervical cancer: a retrospective study[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 536-540.
[4] Terumi Tanigawa, Maki Matoda, Yoichi Aoki, Hidetaka Nomura, Sanshiro Okamoto, Kohei Omatsu, Hiroyuki Kanao, Nobuhiro Takeshima. A case of recurrent smooth muscle tumor of uncertain malignant potential with abdominal dissemination after morcellation[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 648-650.
[5] Mustafa Ayhan Ekici, Ali Can Onal, Caglar Cetin. Likelihood of incidental finding of gynecological cancer in women undergoing hysterectomy for benign indications[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 402-407.
[6] X. Zhang, Y. Fu, X. Zhang, J. Ding, K. Hua. The effect of transcutaneous electrical stimulation treatment in combination with intraoperative nerve staining on sexual function after radical hysterectomy: a pilot study[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 188-191.
[7] M. Sakaguchi, T. Maebayashi, T. Aizawa, N. Ishibashi, T. Saito. High-dose-rate intracavitary brachytherapy for non-palpable and non-visible recurrent vaginal stump tumors after hysterectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 54-59.
[8] H.Ç. Özcan, Ö. Balat, M.G. Uğur, S. Sucu, N.B. Tepe, Ö.K. Karuserci̇, Z. Bozdağ. Extraperitoneal pelvic lymph node dissection with laparotomy in occult invasive cervical cancer found after a simple hysterectomy[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 982-987.
[9] P.-S. Huang, C.-T. Yue, W.-Y. Kao, J.-M. Hwang, H.-W. Kuo, S.-C. Huang. Undifferentiated endometrial sarcoma of the cervix: a case report[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1035-1038.
[10] J. Klat, O. Simetka, C. Povysil. Cervical leiomyosarcoma treated by radical laparoscopic approach: a case report[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1093-1095.
[11] Yangyang Shi, Yongyun Shi, Dabao Wu. A case of placental site trophoblastic tumor and a retrospective analysis[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1096-1099.
[12] M. Pakiž, L. Lukman, N. Kozar. Patients’ and physicians’ expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 781-786.
[13] R. Du, L. Li, S. Ma, X. Tan, S. Zhong, M. Wu. Survival outcomes of Stage IB cervical cancer treated with standard radical hysterectomy[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 810-814.
[14] E. Lajtman, M. Mlynček, T. Kapusta, M. Kubalová. The value of gynecological cancer follow-up: a 15-year single institutional experience[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 619-627.
[15] J.J. Noh, H. Jung, C.H. Choi. Mesonephric adenocarcinoma treated with paclitaxel-carboplatin adjuvant chemotherapy: a case report[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 679-683.
No Suggested Reading articles found!